SIOG 2015

Dr Tew talks to ecancertv at SIOG 2015 about current guidelines and evidence of surgery and chemotherapy in older women with ovarian cancer, and how to coordinate care within a multidisciplinary team.

Dr Karnakis talks to ecancertv at SIOG 2015 about the challenges and pitfalls in terms of the practical aspects of the multidisciplinary care of older adults with cancer.

Prof Audisio talks to ecancertv at SIOG 2015 about how to improve surgical management in colorectal cancer. He discusses the ways in which surgeons can improve cure rates, detection and screening methods.

Dr Gironés talks to ecancertv at SIOG 2015 about data from a subset analysis that focused on the efficacy, chemotherapy schedule and outcomes in elderly patients treated in a clinical setting and compared to younger counterparts with stage III non-small-cell lung cancer.

Prof Stauder talks to ecancertv at SIOG 2015 about patient reported outcomes and how to improve quality of life. He discusses how important quality of life is, and how physicians must move towards including the patient's perspective to make effective and personalised decisions.

Prof Soubeyran talks to ecancertv at SIOG 2015 about frail elderly patients with diffuse large b cell non-hodgkin’s lymphoma.

Prof Jaklitsch talks to ecancertv at SIOG 2015 about new research and accomplishments and challenges for surgery in elderly cancer, especially in lung cancer.

Dr Fracheboud talks to ecancertv at SIOG 2015 about controversial breast cancer screening methods. He discusses the efficacy of mammography screening in women from 70-75, compared to the more common age group of 49 to 69. Based on 14 million screens over 15 years in the Netherlands, Dr Fracheboud reveals that screening is justified in this age group.

Dr Puts talks to ecancertv at SIOG 2015 about the role of comorbidity, frailty and functional status in the decision-making process for older adults with cancer.

Dr Dettino talks to ecancertv at SIOG 2015 about administrative and financial issues in geriatric oncology education, particularly in Brazil. He says that in geriatric oncology, ageism has to be avoided and that despite all of the knowledge gained, there are still gaps in research, education and assistance.

Prof Wildiers talks to ecancertv at SIOG 2015 about geriatric assessment and its pivotal role in detecting other healthcare problems, aside from cancer. Prof Wildiers was awarded the Calabresi award for bringing geriatrics and oncology together.

Dr Khattak talks to ecancertv at SIOG 2015 about the results of a geriatric oncology pilot study. The study looks at the impact of a dedicated geriatric oncology service on the rate of unplanned hospital admissions, and length of stay of older cancer patients.

Dr Büchler talks to ecancertv at SIOG 2015 about age specific cancer guidelines, optimising and individualising treatment in elderly patients with cancer and the challenges in determining the biological age of patients.

Dr Kanesvaran talks to ecancertv at SIOG 2015 about the development of immunotherapy and the latest data about treatment options that have positively impacted the elderly cancer patients, particularly those with lung cancer.

Prof Aapro talks to ecancertv at SIOG 2015 about the multicycle efficacy and safety of nepa, an oral fixed combination of netupitant and palonosetron, in older patients receiving chemotherapy of varying emetogenicity.

Prof Aapro talks to ecancertv at SIOG 2015 about evidence that elderly patients present varying degrees of malnutrition, with a prevalence of 5–30% in those living by themselves to up to 70% in those residing in protected homes.

Dr Derks talks to ecancertv at SIOG 2015 about treatment patterns and relative survival for older patients with non-metastatic breast cancer in three European countries. This preliminary data is from a EURECCA (European Registration of Cancer Care) international comparison.

Prof Livi talks to ecancertv at SIOG 2015 about how radiotherapy can be used in a powerful way to treat elderly breast cancer patients. He also sheds light on how radiotherapy can be effectively used to treat other forms cancer, as an alternative to other treatments such as surgery.

Dr Brain talks to ecancertv at SIOG 2015 about the SIOG education initiative and the Treviso course. This entails teaching and learning to teach oncologists and geriatricians and developing and disseminating specific high-standard guidelines that advocate fine-tuned strategies in elderly cancer patients.

Dr Holmes talks to ecancertv at SIOG 2015 about high-impact trials and other research that has the potential to lead to practice changes in geriatric oncology. She also discusses epidemiology and the adverse outcomes associated with the overuse of medication by older patients.

Dr Steer talks to ecancertv at SIOG 2015 about the challenges and best practices of supportive care for elderly patients. Supportive care is multidisciplinary and involves the care of the patient throughout their cancer journey.

Dr Hurria talks to ecancertv at SIOG 2015 about the evaluation of cancer-specific comprehensive geriatric assessment (CGA) tools in older women with newly diagnosed primary breast cancer.

Prof Eichhorst talks to ecancertv at SIOG 2015 about new challenges in treatment of elderly chronic lymphocytic leukaemia (CLL) patients. Combinations of chemotherapy and antibodies are becoming standard in younger and/or physically fit patients. Concomitant diseases and physically fitness are playing a major role for the selection of treatment for elderly patients. So far, there is no ideal tool to measure the comborbidity burden, but a geriatric assessment before treatment initiation is strongly recommended.